Company profile: Deep Genomics
1.1 - Company Overview
Company description
- Provider of an AI platform that analyzes RNA biology, identifies novel targets, and evaluates therapeutic candidates; BigRNA, the first RNA foundation model for RNA therapeutics that discovers new biological mechanisms and RNA therapeutic candidates; and BigRNA+, which expands BigRNA to include more genetic mechanisms and diseases for broader therapeutic discovery.
Products and services
- BigRNA: A research-grade foundation model for RNA therapeutics that discovers new biological mechanisms and RNA therapeutic candidates
- AI Platform: A modular platform using AI to analyze RNA biology, identify novel targets, and evaluate therapeutic candidates for life-saving genetic therapies
- BigRNA+: An expanded-scope extension of BigRNA that includes more genetic mechanisms and diseases to enable broader RNA therapeutic discovery
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Deep Genomics
PatientIQ
HQ: United States
Website
- Description: Provider of a cloud-based patient outcomes platform for healthcare providers, industry partners, and researchers. Integrates with major EHRs to automate patient-reported data collection from diagnosis to recovery. Delivers biostatistical analytics for benchmarking, predictive modeling, and visualizations, patient engagement tools, eCRF/ePRO electronic data capture, and registry participation and compliance workflows.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PatientIQ company profile →
Antibodies Online
HQ: Germany
Website
- Description: Provider of a vendor-independent marketplace for antibodies, ELISA kits, and related research reagents, offering more than 1.2 million products from over 160 suppliers. Portfolio includes primary (polyclonal, monoclonal, recombinant) and secondary antibodies, lateral flow antibodies, ELISA kits, recombinant proteins, and custom antibody services with Rockland Immunochemicals, Inc., serving 2,000+ companies and research institutions in 53 countries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Antibodies Online company profile →
Longboat
HQ: Ireland
Website
- Description: Provider of well-designed, practical technology solutions that address investigator site engagement and protocol compliance challenges in global clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Longboat company profile →
Schrödinger
HQ: United States
Website
- Description: Provider of physics-based molecular discovery and design software platforms for therapeutics and materials research, supporting biopharmaceutical and industrial companies, academic institutions, and government labs; offers collaborative and wholly-owned drug discovery programs and pipeline, educational resources and courses, and tools to model and optimize metals, alloys, and ceramics via computational workflows and machine learning.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Schrödinger company profile →
Phlex
HQ: United Kingdom
Website
- Description: Provider of specialist comprehensive administrative services for the clinical trial process across pharmaceutical, biotechnology, medical device, and healthcare industries, and eTMF solutions including PhlexTMF to ensure complete, timely, accurate Trial Master Files; TMF Quality Review; TMF Heatmaps; TMF Migrations & Imports; PhlexTMF for Viewing; and a TMF Health Score Survey.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Phlex company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Deep Genomics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Deep Genomics
2.2 - Growth funds investing in similar companies to Deep Genomics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Deep Genomics
4.2 - Public trading comparable groups for Deep Genomics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →